Immunology and Microbiology
Enterococcus faecium
100%
Enterococcus faecalis
89%
Minimum Inhibitory Concentration
69%
Enterococcus
67%
Methicillin-Resistant Staphylococcus Aureus
57%
Vancomycin-Resistant Enterococcus
51%
Inoculum
49%
Antimicrobial Resistance
47%
Whole Genome Sequencing
46%
Staphylococcus aureus
44%
Methicillin Susceptible Staphylococcus Aureus
40%
Infectious Agent
38%
Endocarditis
38%
Cell Membrane
37%
Enterobacterales
31%
Lineage
27%
Pseudomonas aeruginosa
27%
Antimicrobial Peptides
24%
Klebsiella pneumoniae
24%
Antibiotic Sensitivity
24%
Vancomycin Resistance
23%
Prevalence
22%
Plasmid
20%
Colony-Forming Unit
19%
Colony Forming Unit S
16%
Bacteriophage
16%
Streptococcus Mitis
16%
Drug Megadose
16%
Molecular Epidemiology
15%
Phylogenomics
15%
Glycopeptide
14%
Etest
13%
Biofilm
12%
Enterococcus gallinarum
12%
Peritonitis
12%
Broth Dilution
12%
Peptidoglycan
12%
Penicillin Binding Protein
11%
Penicillin
11%
Escherichia coli
11%
Promoter Region
11%
Wild Type
11%
Endocardium
11%
Bactericidal Activity
10%
Pharmacodynamics
10%
Western Blot
10%
Allele
10%
Rat Model
10%
Gene Cluster
10%
Stop Codon
10%
Pharmacology, Toxicology and Pharmaceutical Science
Daptomycin
81%
Bloodstream Infection
48%
Enterococcus faecium
48%
Infection
43%
Vancomycin-Resistant Enterococcus
35%
Enterococcus faecalis
33%
Vancomycin
33%
Enterococcus
32%
Antimicrobial Resistance
30%
Linezolid
25%
Antibiotics
23%
Methicillin-Resistant Staphylococcus Aureus
23%
Infectious Agent
21%
Endocarditis
20%
Bacterial Endocarditis
20%
Staphylococcus aureus
19%
Antiinfective Agent
17%
Ampicillin
17%
Ceftriaxone
14%
Enterococcal Infection
14%
Carbapenem
13%
Ceftaroline
10%
Combination Therapy
10%
Pharmacodynamics
10%
Prospective Cohort Study
9%
Rat Model
9%
Pharmacokinetic
8%
Cohort Study
8%
Diseases
7%
Pseudomonas aeruginosa
7%
Cardiolipin
7%
Lactam
7%
Synthetase
7%
Epidemiology
7%
Minimum Inhibitory Concentration
7%
Soft Tissue Infection
6%
Ceftolozane
6%
Streptococcus Group A
6%
Methicillin Susceptible Staphylococcus Aureus
6%
Streptococcus Mitis
6%
Aminoglycoside
6%
Monotherapy
6%
Phospholipid
6%
Prevalence
6%
Malignant Neoplasm
5%
Gentamicin
5%
Cephalosporin Derivative
5%
Penicillin Binding Protein
5%
Penicillin
5%
Keyphrases
Daptomycin
69%
Enterococcus Faecium
37%
Enterococcus Faecalis
35%
Enterococcus
27%
Methicillin-resistant Staphylococcus Aureus
26%
LiaFSR
20%
Antibiotics
19%
Infective Endocarditis
16%
Liar
15%
Antimicrobial
15%
Vancomycin Resistance
15%
Daptomycin Resistance
14%
E. Faecalis
14%
Cefazolin Inoculum Effect
14%
Vancomycin
13%
Carbapenem-resistant Enterobacterales
12%
Ampicillin
11%
Cell Membrane
11%
β-lactamase
10%
Staphylococcus Aureus Bloodstream Infection
10%
COVID-19
10%
Colombia
10%
Antimicrobial Peptides
10%
Bacteremia
10%
Patients with Cancer
9%
Inoculum Effect
9%
Endocarditis
9%
Bloodstream Infection
9%
Vancomycin-resistant Enterococci
9%
Antimicrobial Resistance
8%
Cefazolin
8%
Monotherapy
8%
High Inoculum
8%
Adaptation
8%
Enterococcal Infections
7%
Cardiolipin Synthase
7%
Risk Factors
7%
VanA
7%
30-day Mortality
7%
Whole Genome Sequencing
7%
Lactams
7%
Increased Mortality
6%
Rat Model
6%
VanA Gene
6%
Tedizolid
6%
Cefiderocol
6%
Enterococcal Endocarditis
6%
Antibacterial Resistance
6%
Leadership Group
6%
Antimicrobial Chemotherapy
6%